37 reports

Boston Scientific (U. S. ) is one of the companies providing FDA approved ablation device for asthma treatment.

  • Catheter
  • World
  • Market Size
  • Boston Scientific Corporation
  • CONMED Corporation

Spacer devices used for asthma are also incorporated with medical tubing.

  • Catheter
  • Synthetic Resin
  • Market Size
  • Lubrizol Corporation
  • Teleflex Incorporated
  • KEY FACTORS DRIVING THE ADOPTION OF SHORT PIVCS IN EMERGING ECONOMIES

About Short PIVC A short peripheral intravenous catheter (PIVC) is a long, thin tube that is used to inject fluid or medication directly into a vein or to draw blood samples for testing. A needle is inserted and subsequently removed from a peripheral vein (i.e., veins found in the arms, hands, legs, or feet), leaving a small...

  • Catheter
  • World
  • Forecast
  • B. Braun Medical
  • Terumo Corporation
  • BOSTON SCIENTIFIC

In October 2010, BSC acquired Asthmatx, Inc., adding less-invasive, catheter- based bronchial thermoplasty procedure for the treatment of severe persistent asthma.

  • Catheter
  • World
  • Jude Medical, Inc.
  • Medtronic, Inc.
  • Terumo Corporation
  • HATTLER CATHETER - PRODUCT DESCRIPTION
  • HATTLER CATHETER - PRODUCT STATUS

The metered dose inhaler (MDI) remains one of the most popular delivery devices for asthma and COPD medications, but one of the most difficult challenges for patients is knowing when to replace their inhaler.

  • Catheter
  • Clinical Trial
  • Therapy
  • United States
  • GlobalData's company
  • Becton, Dickinson and Company (U.S.)
  • Month & Year

According to the Asthma and Allergy Foundation of America, asthma is the fifth-leading chronic disease in the U. S.

  • Catheter
  • North America
  • United States
  • World
  • Market Size
  • HATTLER CATHETER - PRODUCT DESCRIPTION
  • HATTLER CATHETER - PRODUCT STATUS

We believe this clinical study will demonstrate that the Resmon PRO FULL is a valuable device to diagnose and manage COPD and asthma.

  • Catheter
  • United States
  • Company
  • Company Financials
  • GlobalData's company

PRESENTED POST APPROVAL STUDY RESULTS AT THE AMERICAN THORACIC SOCIETY INTERNATIONAL CONFERENCE THAT DEMONSTRATED THE ALAIR™BRONCHIAL THERMOPLASTY SYSTEM REDUCED COMPLICATIONS, INCLUDING SEVERE ASTHMA EXACERBATIONS AND ASTHMA-RELATED HOSPITALIZATIONS, IN ADULT PATIENTS WITH SEVERE

  • Catheter
  • Clinical Trial
  • Interventional Cardiology Device
  • Medical Device
  • Boston Scientific Corporation

S. filing in persistent uncontrolled asthma expected to take place in Q##.

  • Cardiology
  • Catheter
  • Interventional Cardiology Device
  • France
  • Sanofi S.A.

We are pleased by the progress in R& D demonstrated by the positive phase ## topline results in asthma for Dupixent® and the recent advances of cemiplimab, our anti PD-##, in oncology. "

  • Catheter
  • Clinical Trial
  • Hospital
  • Urology Device
  • Sanofi S.A.

It is mostly used by asthma and COPD patients.

  • Catheter
  • Eastern Europe
  • Russia
  • Market Size
  • Pfizer Inc.

FILING IN PERSISTENT UNCONTROLLED ASTHMA EXPECTED TO TAKE PLACE IN Q##.

  • Catheter
  • Hospital
  • Southern Europe
  • Western Europe
  • Market Size

Presented post approval study results at the American Thoracic Society International Conference that demonstrated the Alair™ Bronchial Thermoplasty System reduced complications, including severe asthma exacerbations and asthma-related hospitalizations, in adult patients with severe

  • Catheter
  • Therapy
  • Ultrasound
  • United States
  • Volcano

PRESENTED POST APPROVAL STUDY RESULTS AT THE AMERICAN THORACIC SOCIETY INTERNATIONAL CONFERENCE THAT DEMONSTRATED THE ALAIR™BRONCHIAL THERMOPLASTY SYSTEM REDUCED COMPLICATIONS, INCLUDING SEVERE ASTHMA EXACERBATIONS AND ASTHMA-RELATED HOSPITALIZATIONS, IN ADULT PATIENTS WITH SEVERE

  • Catheter
  • Clinical Trial
  • Electrophysiology Device
  • United States
  • CathRx Ltd

FILING IN PERSISTENT UNCONTROLLED ASTHMA EXPECTED TO TAKE PLACE IN Q##.

  • Cardiology
  • Catheter
  • France
  • Western Europe
  • Market Size

PRESENTED POST APPROVAL STUDY RESULTS AT THE AMERICAN THORACIC SOCIETY INTERNATIONAL CONFERENCE THAT DEMONSTRATED THE ALAIR™ BRONCHIAL THERMOPLASTY SYSTEM REDUCED COMPLICATIONS, INCLUDING SEVERE ASTHMA EXACERBATIONS AND ASTHMA-RELATED HOSPITALIZATIONS, IN ADULT PATIENTS WITH SEVERE

  • Catheter
  • Clinical Trial
  • Drug Discovery And Development
  • Therapy
  • Boston Scientific Corporation

ONE UNIT REFERS TO ONE CDU.

  • Catheter
  • Peripheral Vascular Device
  • East Asia
  • Japan
  • Market Size

Presented post approval study results at the American Thoracic Society International Conference that demonstrated the Alair™ Bronchial Thermoplasty System reduced complications, including severe asthma exacerbations and asthma-related hospitalizations, in adult patients with severe

  • Catheter
  • North America
  • United States
  • Company Financials
  • Becton Property Group

One unit refers to one CDU.

  • Catheter
  • United States
  • Company Financials
  • Market Size
  • MiMedx Group, Inc.

PRESENTED POST APPROVAL STUDY RESULTS AT THE AMERICAN THORACIC SOCIETY INTERNATIONAL CONFERENCE THAT DEMONSTRATED THE ALAIR™ BRONCHIAL THERMOPLASTY SYSTEM REDUCED COMPLICATIONS, INCLUDING SEVERE ASTHMA EXACERBATIONS AND ASTHMA-RELATED HOSPITALIZATIONS, IN ADULT PATIENTS WITH SEVERE

  • Cardiovascular Devices
  • Catheter
  • Peripheral Vascular Device
  • North America
  • Market Size

" There are several new drugs for severe asthma that target the more allergic, or eosinophilic, type of severe asthma.

  • Catheter
  • Healthcare
  • North America
  • United States
  • Market Size

PRESENTED POST APPROVAL STUDY RESULTS AT THE AMERICAN THORACIC SOCIETY INTERNATIONAL CONFERENCE THAT DEMONSTRATED THE ALAIR™ BRONCHIAL THERMOPLASTY SYSTEM REDUCED COMPLICATIONS, INCLUDING SEVERE ASTHMA EXACERBATIONS AND ASTHMA-RELATED HOSPITALIZATIONS, IN ADULT PATIENTS WITH SEVERE

  • Catheter
  • Medical Device
  • North America
  • United States
  • Medtronic, Inc.

PRESENTED POST APPROVAL STUDY RESULTS AT THE AMERICAN THORACIC SOCIETY INTERNATIONAL CONFERENCE THAT DEMONSTRATED THE ALAIR™ BRONCHIAL THERMOPLASTY SYSTEM REDUCED COMPLICATIONS, INCLUDING SEVERE ASTHMA EXACERBATIONS AND ASTHMA-RELATED HOSPITALIZATIONS, IN ADULT PATIENTS WITH SEVERE

  • Catheter
  • Clinical Trial
  • Hospital
  • Robotics
  • Boston Scientific Corporation

One unit refers to one ultrasound catheters.

  • Catheter
  • Pharmaceutical
  • United States
  • Company
  • GlobalData's company

PRESENTED POST APPROVAL STUDY RESULTS AT THE AMERICAN THORACIC SOCIETY INTERNATIONAL CONFERENCE THAT DEMONSTRATED THE ALAIR™ BRONCHIAL THERMOPLASTY SYSTEM REDUCED COMPLICATIONS, INCLUDING SEVERE ASTHMA EXACERBATIONS AND ASTHMA-RELATED HOSPITALIZATIONS, IN ADULT PATIENTS WITH SEVERE

  • Catheter
  • Health Services
  • Medical Device
  • North America
  • Market Size

ONE UNIT REFERS TO ONE CDU.

  • Cardiology
  • Catheter
  • North America
  • Market Size
  • Medtronic, Inc.

Presented post approval study results at the American Thoracic Society International Conference that demonstrated the Alair™ Bronchial Thermoplasty System reduced complications, including severe asthma exacerbations and asthma-related hospitalizations, in adult patients with severe

  • Catheter
  • Medical Device
  • United States
  • Market Size
  • Corindus, Inc.

THESE PREMIUM DIGITAL DEVICES ARE CHANGING THE WAY WE DIAGNOSE AND TREAT CARDIOVASCULAR AND PULMONARY DISEASES, INCLUDING HYPERTENSION, HEART FAILURE, ASTHMA, COPD AND SLEEP DISORDERS.

  • Catheter
  • Australasia
  • Australia
  • Oceania
  • Market Size

Presented post approval study results at the American Thoracic Society International Conference that demonstrated the Alair™ Bronchial Thermoplasty System reduced complications, including severe asthma exacerbations and asthma-related hospitalizations, in adult patients with severe

  • Catheter
  • Clinical Trial
  • Drug Discovery And Development
  • Interventional Cardiology Device
  • GlobalData's company

PRESENTED POST APPROVAL STUDY RESULTS AT THE AMERICAN THORACIC SOCIETY INTERNATIONAL CONFERENCE THAT DEMONSTRATED THE ALAIR™ BRONCHIAL THERMOPLASTY SYSTEM REDUCED COMPLICATIONS, INCLUDING SEVERE ASTHMA EXACERBATIONS AND ASTHMA-RELATED HOSPITALIZATIONS, IN ADULT PATIENTS WITH SEVERE

  • Catheter
  • Medical Device
  • Pharmaceutical
  • United States
  • Company